Kymera Therapeutics, Inc. - COM (KYMR)

Q4 2021 13F Holders as of 12/31/2021

Type / Class
Equity / COM
Number of holders
124
Total Shares
43M
Shares change
+1.99M
Total reported value, excl. options
$2.73B
Value change
+$129M
Put/Call ratio
0.03
Number of buys
73
Number of sells
-39
Price
$63.49
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.